The results demonstrated that GPSM3 expression was most strongly correlated with levels of CD8+ T cells, B cells, macrophage, and myeloid dendritic cells in subtypes basal and HER2 of breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.